ECNP Medicines Chest
ECNP assisted clinical researchers to obtain access to pharmacological tools important for the pursuit of their studies. Frequently, many potentially useful drugs are not exploited in clinical research for a variety of reasons: for example, they are poorly documented by companies in the event that their development is discontinued. In addition, clinical researchers are frequently unaware which agents are potentially available for research purposes, how to acquire such drugs, and the conditions under which they can be exploited.
We hope we helped overcome such problems by acting as an intermediary between companies and researchers, and several pharmaceutical companies participated in this endeavour.
The latest ECNP Medicines Chest report includes:
- Other compounds
- Funding opportunities